Health Care Stocks Higher

Health care stocks were holding on to slim gains Monday, with the NYSE Health Care Index rising almost 0.2% while shares of health care companies in the S&P 500 were up nearly 0.4% as a group. In company news, Radius Health (RDUS) jumped out to a big gain on Monday, with the biopharmaceuticals company starting today’s session with a 27.5% spike to $41.99 a share after a rival drugmaker’s experiemental treatment for osteoporosis may have produced an unexpected cardiovascular safety signal during late-stage testing.

U.S. regulators approved on April 28 Radius’ Tymlos osteoporosis drug treatment for post-menopausal women. Unlike Amgen (AMGN) – which this morning reported offsetting phase III trial results for its Evenity drug candidate – Tymlos had no increased cardiovascular risk although the U.S. Food and Drug Administration required the company to include a package insert with the new drug warning about the potential risk of osteosarcoma.

By Garrett Hatch